Variant report

Variant	esv3421772
Chromosome Location	chr8:1762445-1766643
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr8:1762412-1762469	H1-hESC	embryonic stem cell:	n/a	n/a
2	CREB1	chr8:1765035-1765490	H1-hESC	embryonic stem cell:	n/a	n/a
3	CREB1	chr8:1765051-1765569	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr8:1766535-1766588	K562	blood:	n/a	chr8:1766554-1766572 chr8:1766556-1766577 chr8:1766557-1766570
5	CTCF	chr8:1766505-1766701	K562	blood:	n/a	chr8:1766554-1766572 chr8:1766556-1766577 chr8:1766557-1766570
6	CTCF	chr8:1764535-1764624	GM10248	blood:	n/a	n/a
7	CTCF	chr8:1766480-1766630	HFF-Myc	foreskin:	n/a	chr8:1766554-1766572 chr8:1766556-1766577 chr8:1766557-1766570
8	CTCF	chr8:1766420-1766570	SAEC	small airway:	n/a	chr8:1766557-1766570
9	CTCF	chr8:1766420-1766570	HCPEpiC	choroid plexus:	n/a	chr8:1766557-1766570
10	CTCF	chr8:1763180-1763330	HBMEC	blood vessel:	n/a	n/a
11	CTCF	chr8:1766440-1766590	HFF-Myc	foreskin:	n/a	chr8:1766554-1766572 chr8:1766556-1766577 chr8:1766557-1766570
12	CTCF	chr8:1766440-1766590	HEK293	kidney:	n/a	chr8:1766554-1766572 chr8:1766556-1766577 chr8:1766557-1766570
13	CTCF	chr8:1766420-1766570	NHEK	skin:	n/a	chr8:1766557-1766570
14	CTCF	chr8:1766560-1766710	NHEK	skin:	n/a	n/a
15	CTCF	chr8:1766460-1766610	K562	blood:	n/a	chr8:1766554-1766572 chr8:1766556-1766577 chr8:1766557-1766570
16	CTCF	chr8:1766400-1766550	SAEC	small airway:	n/a	n/a
17	CTCF	chr8:1766500-1766650	Hela-S3	cervix:	n/a	chr8:1766554-1766572 chr8:1766556-1766577 chr8:1766557-1766570
18	CTCF	chr8:1766400-1766550	RPTEC	kidney:	n/a	n/a
19	CTCF	chr8:1764537-1764562	Pancreas_OC	pancreas:	n/a	n/a
20	CTCF	chr8:1766476-1766573	MCF-7	breast:	n/a	chr8:1766554-1766572 chr8:1766557-1766570
21	CTCF	chr8:1766461-1766646	H1-hESC	embryonic stem cell:	n/a	chr8:1766554-1766572 chr8:1766556-1766577 chr8:1766557-1766570
22	CTCF	chr8:1766386-1766626	NHEK	skin:	n/a	chr8:1766554-1766572 chr8:1766556-1766577 chr8:1766557-1766570
23	CTCF	chr8:1766440-1766590	HBMEC	blood vessel:	n/a	chr8:1766554-1766572 chr8:1766556-1766577 chr8:1766557-1766570
24	EGR1	chr8:1765231-1765403	K562	blood:	n/a	n/a
25	EGR1	chr8:1764761-1765227	ECC-1	luminal epithelium:	n/a	chr8:1765009-1765020 chr8:1765010-1765019 chr8:1765008-1765021 chr8:1765007-1765021 chr8:1765003-1765025 chr8:1765008-1765021 chr8:1765009-1765020 chr8:1765007-1765022 chr8:1765009-1765019 chr8:1765009-1765019 chr8:1765008-1765021 chr8:1765008-1765021 chr8:1765009-1765018
26	EGR1	chr8:1764834-1765165	K562	blood:	n/a	chr8:1765009-1765020 chr8:1765010-1765019 chr8:1765008-1765021 chr8:1765007-1765021 chr8:1765003-1765025 chr8:1765008-1765021 chr8:1765009-1765020 chr8:1765007-1765022 chr8:1765009-1765019 chr8:1765009-1765019 chr8:1765008-1765021 chr8:1765008-1765021 chr8:1765009-1765018
27	EGR1	chr8:1765219-1765470	K562	blood:	n/a	n/a
28	EGR1	chr8:1764868-1765187	K562	blood:	n/a	chr8:1765009-1765020 chr8:1765010-1765019 chr8:1765008-1765021 chr8:1765007-1765021 chr8:1765003-1765025 chr8:1765008-1765021 chr8:1765009-1765020 chr8:1765007-1765022 chr8:1765009-1765019 chr8:1765009-1765019 chr8:1765008-1765021 chr8:1765008-1765021 chr8:1765009-1765018
29	EGR1	chr8:1764821-1765220	ECC-1	luminal epithelium:	n/a	chr8:1765009-1765020 chr8:1765010-1765019 chr8:1765008-1765021 chr8:1765007-1765021 chr8:1765003-1765025 chr8:1765008-1765021 chr8:1765009-1765020 chr8:1765007-1765022 chr8:1765009-1765019 chr8:1765009-1765019 chr8:1765008-1765021 chr8:1765008-1765021 chr8:1765009-1765018
30	FOSL2	chr8:1764366-1764683	HepG2	liver:	n/a	n/a
31	FOXA1	chr8:1764996-1765248	T-47D	breast:	n/a	n/a
32	GABPA	chr8:1764391-1764622	Hela-S3	cervix:	n/a	n/a
33	GABPA	chr8:1764347-1764616	GM12878	blood:	n/a	n/a
34	HMGN3	chr8:1765666-1765828	K562	blood:	n/a	n/a
35	JUND	chr8:1764379-1764644	HepG2	liver:	n/a	n/a
36	MAX	chr8:1765054-1765579	H1-hESC	embryonic stem cell:	n/a	n/a
37	MAX	chr8:1765055-1765592	H1-hESC	embryonic stem cell:	n/a	n/a
38	MYC	chr8:1762310-1762471	HUVEC	blood vessel:	n/a	n/a
39	POLR2A	chr8:1764795-1764867	H1-hESC	embryonic stem cell:	n/a	n/a
40	POLR2A	chr8:1765357-1765363	HUVEC	blood vessel:	n/a	n/a
41	RAD21	chr8:1766324-1766690	H1-hESC	embryonic stem cell:	n/a	chr8:1766555-1766574
42	RCOR1	chr8:1764918-1765797	IMR90	lung:	n/a	n/a
43	RCOR1	chr8:1765451-1765453	K562	blood:	n/a	n/a
44	REST	chr8:1764313-1764464	PANC-1	pancreas:	n/a	n/a
45	REST	chr8:1764648-1764844	PANC-1	pancreas:	n/a	n/a
46	SRF	chr8:1764390-1764625	GM12878	blood:	n/a	n/a
47	UBTF	chr8:1765830-1765845	K562	blood:	n/a	n/a
48	ZNF143	chr8:1762294-1762470	H1-hESC	embryonic stem cell:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr8:1764329-1764379	AoSMC	blood vessel:	n/a
2	chr8:1765074-1765124	CMK	blood:	n/a
3	chr8:1765309-1765359	HepG2	liver:	n/a
4	chr8:1765336-1765386	HIPEpiC	eye:	n/a
5	chr8:1765296-1765346	HepG2	liver:	n/a
6	chr8:1765679-1765729	LNCaP	prostate:	n/a
7	chr8:1765312-1765362	HMEC	breast:	n/a
8	chr8:1765421-1765471	K562	blood:	n/a
9	chr8:1765312-1765362	HNPCEpiC	eye:	n/a
10	chr8:1765421-1765471	GM19239	blood:	n/a
11	chr8:1765358-1765408	AoSMC	blood vessel:	n/a
12	chr8:1765066-1765116	IMR90	lung:	fetal
13	chr8:1765336-1765386	Caco-2	colon:	n/a
14	chr8:1765358-1765408	NH-A	brain:	n/a
15	chr8:1766126-1766176	CMK	blood:	n/a
16	chr8:1765336-1765386	SK-N-MC	brain:	n/a
17	chr8:1765309-1765359	H1-hESC	embryonic stem cell:	embryo
18	chr8:1765358-1765408	HRE	kidney:	n/a
19	chr8:1765217-1765267	ECC-1	luminal epithelium:	n/a
20	chr8:1765312-1765362	BE2_C	brain:	n/a
21	chr8:1765820-1765870	HPAEpiC	pulmonary alveolar:	n/a
22	chr8:1765312-1765362	NHBE	bronchial:	n/a
23	chr8:1765477-1765527	HCT-116	colon:	n/a
24	chr8:1765477-1765527	K562	blood:	n/a
25	chr8:1765217-1765267	HUVEC	blood vessel:	n/a
26	chr8:1764878-1764928	MCF10A-Er-Src	breast:	n/a
27	chr8:1764329-1764379	CMK	blood:	n/a
28	chr8:1764329-1764379	AG09319	gingival:	n/a
29	chr8:1765309-1765359	Hela-S3	cervix:	n/a
30	chr8:1765217-1765267	HNPCEpiC	eye:	n/a
31	chr8:1766281-1766331	SK-N-SH_RA	brain:	n/a
32	chr8:1765477-1765527	SKMC	muscle:	n/a
33	chr8:1765477-1765527	AG04450	lung:	fetal
34	chr8:1765387-1765437	MCF10A-Er-Src	breast:	n/a
35	chr8:1765387-1765437	LNCaP	prostate:	n/a
36	chr8:1765074-1765124	HNPCEpiC	eye:	n/a
37	chr8:1765336-1765386	HAEpiC	amniotic membrane:	n/a
38	chr8:1765066-1765116	LNCaP	prostate:	n/a
39	chr8:1765820-1765870	GM06990	blood:	n/a
40	chr8:1765679-1765729	PFSK-1	brain:	n/a
41	chr8:1765296-1765346	SAEC	small airway:	n/a
42	chr8:1765309-1765359	HCM	heart:	n/a
43	chr8:1766281-1766331	BE2_C	brain:	n/a
44	chr8:1764878-1764928	HIPEpiC	eye:	n/a
45	chr8:1765336-1765386	IMR90	lung:	fetal
46	chr8:1765358-1765408	AG09319	gingival:	n/a
47	chr8:1764878-1764928	GM06990	blood:	n/a
48	chr8:1765066-1765116	SAEC	small airway:	n/a
49	chr8:1766281-1766331	A549	lung:	n/a
50	chr8:1764878-1764928	HCM	heart:	n/a

No.	Distal block	Cell Line	Cell type
1	chr8:1762249..1764109-chr8:1770396..1773299,2	K562	blood:
2	chr8:1754619..1756376-chr8:1765622..1768454,2	K562	blood:
3	chr8:1764550..1766629-chr8:1770415..1772487,2	K562	blood:
4	chr8:1757521..1759166-chr8:1766213..1768564,2	K562	blood:
5	chr8:1710918..1712882-chr8:1766102..1768969,2	K562	blood:
6	chr8:1710901..1715165-chr8:1763143..1767602,4	K562	blood:

miRNA name	Chromosome Location	mirBase accession
hsa-miR-596	chr8:1765412-1765432	MIMAT0003264

Variant related genes	Relation type
MIR596	TF binding region
MIR596	CpG island
ENSG00000104728	chromatin interactions
ENSG00000182372	chromatin interactions
ENSG00000253982	chromatin interactions
LGALS3BP	Mature miRNA region

Extended variants
information (count: 286 )
Associated
traits (count: 118 )

Variant overlapped rSNPs/rCNVs (count:286 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs529310524	chr8:1762475-1762476	Enhancers Weak transcription Bivalent Enhancer Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs565959681	chr8:1762538-1762539	Enhancers Weak transcription Bivalent Enhancer Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs370688080	chr8:1762564-1762565	Enhancers Weak transcription Bivalent Enhancer Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs549660123	chr8:1762571-1762572	Enhancers Weak transcription Bivalent Enhancer Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs559481872	chr8:1762572-1762573	Enhancers Weak transcription Bivalent Enhancer Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs374352378	chr8:1762638-1762639	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs569565005	chr8:1762662-1762663	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs12676539	chr8:1762663-1762664	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs551926518	chr8:1762697-1762698	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs541893797	chr8:1762726-1762727	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs563563914	chr8:1762740-1762741	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs143327165	chr8:1762747-1762748	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs7007130	chr8:1762754-1762755	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs553606461	chr8:1762764-1762765	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs190648453	chr8:1762774-1762775	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs146729107	chr8:1762789-1762790	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs555780863	chr8:1762802-1762803	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs373680433	chr8:1762865-1762866	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs141280953	chr8:1762882-1762883	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs545009682	chr8:1762920-1762921	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs565058448	chr8:1762946-1762947	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs572170682	chr8:1762986-1762987	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs566922019	chr8:1762988-1762989	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs374122701	chr8:1763018-1763019	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs529446496	chr8:1763021-1763022	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs75386516	chr8:1763024-1763025	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs575645433	chr8:1763025-1763026	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs117303182	chr8:1763050-1763051	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs182742912	chr8:1763052-1763053	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs73538705	chr8:1763138-1763139	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs564404181	chr8:1763159-1763160	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs74426001	chr8:1763179-1763180	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs79981845	chr8:1763182-1763183	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs547430454	chr8:1763199-1763200	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
35	rs528345898	chr8:1763205-1763206	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
36	rs112403961	chr8:1763207-1763208	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
37	rs12678737	chr8:1763217-1763218	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
38	rs4308779	chr8:1763227-1763228	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs575647897	chr8:1763271-1763272	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
40	rs142363595	chr8:1763289-1763290	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
41	rs112158571	chr8:1763401-1763402	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs112051512	chr8:1763423-1763424	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs74752748	chr8:1763440-1763441	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs11136426	chr8:1763499-1763500	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs376925186	chr8:1763513-1763514	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs540856283	chr8:1763520-1763521	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs561111503	chr8:1763523-1763524	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs550629332	chr8:1763542-1763543	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs546377360	chr8:1763546-1763547	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs543181492	chr8:1763592-1763593	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:118)

Disease	PMID	Source
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Congenital diaphragmatic hernia	21341218	CNVD
Cancer	18840272	CNVD
Pilocytic astrocytoma	18622384	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	16573809	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
abnormal development	18461090	CNVD
Crohn''s disease	19220326	CNVD
Psoriasis	19220326	CNVD
Prostate cancer	21965145	CNVD
Prostate cancer	18515986	CNVD
Chronic obstructive pulmonary disease	20378733	CNVD
Autism	18414403	CNVD
Cancer	21183584	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	17603634	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Ovarian cancer	20844748	CNVD
Cervical cancer	17311676	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Schizophrenia	20877625	CNVD
Disorders of sex development	21048976	CNVD
Colorectal cancer	16272173	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	17001317	CNVD
Thyroid cancer	19087340	CNVD
Multiple myeloma	16616336	CNVD
Hepatocellular carcinoma	22174799	CNVD
Heart disease	21282601	CNVD
T-cell lymphomas	19863542	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	21297112	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	17133270	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Breast cancer	17393978	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Breast cancer	20837533	CNVD
Squamous cell cancer	21044232	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	22429812	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	21264507	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	21088497	CNVD
Breast cancer	20940404	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Gastric cancer	17167181	CNVD
Prostate cancer	16705090	CNVD
8p-syndrome	17576883	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Prostate cancer	17245344	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Cancer	20164919	CNVD
Breast cancer	21785460	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
Ductal carcinoma	22052326	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Epilepsy	22083797	CNVD
Acute myeloid leukemia	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21364760	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Breast cancer	20932292	CNVD
Congenital diaphragmatic hernia	21064195	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Ependymoma	20639864	CNVD
Ovarian cancer	22355333	CNVD
Tetralogy of Fallot	22912587	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Lung adenocarcinoma	21935476	CNVD

Chromatin state (count:371 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:1750800-1765000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr8:1758000-1765000	Weak transcription	Left Ventricle	heart
3	chr8:1759400-1763400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
4	chr8:1760800-1763000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
5	chr8:1761000-1762800	Enhancers	Lung	lung
6	chr8:1761000-1764600	Enhancers	HUES6 Cell Line	embryonic stem cell
7	chr8:1761200-1762800	Enhancers	H9 Cell Line	embryonic stem cell
8	chr8:1761200-1762800	Enhancers	iPS-20b Cell Line	embryonic stem cell
9	chr8:1761200-1763200	Enhancers	ES-I3 Cell Line	embryonic stem cell
10	chr8:1761200-1763400	Enhancers	HUES64 Cell Line	embryonic stem cell
11	chr8:1761400-1762600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
12	chr8:1761400-1762800	Enhancers	Primary B cells from peripheral blood	blood
13	chr8:1761400-1763000	Enhancers	HUVEC	blood vessel
14	chr8:1761400-1763400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
15	chr8:1761400-1763400	Enhancers	iPS-15b Cell Line	embryonic stem cell
16	chr8:1761400-1763600	Enhancers	H1 Cell Line	embryonic stem cell
17	chr8:1761400-1764400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr8:1761600-1762800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
19	chr8:1761600-1762800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
20	chr8:1761600-1762800	Enhancers	Pancreas	Pancrea
21	chr8:1761600-1762800	Enhancers	Spleen	Spleen
22	chr8:1761600-1763000	Enhancers	iPS-18 Cell Line	embryonic stem cell
23	chr8:1761600-1763000	Enhancers	Fetal Muscle Leg	muscle
24	chr8:1761600-1763200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
25	chr8:1761600-1763400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
26	chr8:1761600-1763600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
27	chr8:1761600-1763600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
28	chr8:1761800-1762600	Active TSS	Brain Angular Gyrus	brain
29	chr8:1761800-1762600	Enhancers	Brain Anterior Caudate	brain
30	chr8:1761800-1762600	Active TSS	Brain Substantia Nigra	brain
31	chr8:1762000-1762600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
32	chr8:1762000-1762800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
33	chr8:1762000-1763000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
34	chr8:1762000-1763400	Enhancers	Cortex derived primary cultured neurospheres	brain
35	chr8:1762000-1771400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
36	chr8:1762200-1762600	Bivalent Enhancer	Primary T cells from cord blood	blood
37	chr8:1762200-1762600	Enhancers	Adipose Nuclei	Adipose
38	chr8:1762200-1762800	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
39	chr8:1762200-1762800	Enhancers	Primary T helper cells PMA-I stimulated	--
40	chr8:1762200-1762800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
41	chr8:1762200-1763000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
42	chr8:1762200-1764800	Weak transcription	Right Atrium	heart
43	chr8:1762400-1762600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
44	chr8:1762400-1762600	Active TSS	Brain Cingulate Gyrus	brain
45	chr8:1762400-1762600	Active TSS	Brain Hippocampus Middle	brain
46	chr8:1762400-1762600	Active TSS	Brain Inferior Temporal Lobe	brain
47	chr8:1762400-1762600	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
48	chr8:1762400-1762600	Enhancers	Fetal Brain Female	brain
49	chr8:1762400-1763000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
50	chr8:1762400-1763200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links